Progenics Pharmaceuticals, Inc.. (PGNX) NASDAQ
$4.10 - (-)
Market Cap: $355.04M
As of 06/19/20 12:00 AM EDT. Market closed.
Progenics Pharmaceuticals, Inc.. (PGNX)
NASDAQ
$4.10
- (-)
Market Cap: $355.04M
As of 06/19/20 12:00 AM EDT. Market closed.
Add to Portfolio
Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon in 1986 and is headquartered in New York, ... read more
Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon in 1986 and is headquartered in New York, NY. read less
COMPANY PROFILE
Sector
Health Technology
Industry
Biotechnology
CEO
Mary Anne Heino
Full Time Employees
105
CEO Compensation (Base)
$632,755
CEO Compensation (Total)
$1.87M
Sector
Health Technology
Industry
Biotechnology
CEO
Mary Anne Heino
Full Time Employees
105
CEO Compensation (Base)
$632,755
CEO Compensation (Total)
$1.87M
Address
One World Trade Center, 47th Floor Suite J, NY, New York, 1000.
PRICE CHART FOR PROGENICS PHARMACEUTICALS, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$4.10
Days Range
- - -
52 week range
$1.89 - $6.37
Volume
0
Avg. Volume (30 days)
1,918,553
Market Cap
$355.04M
Dividend Yield
-
P/E
-
Shares Outstanding
86,596,000
Open
-
Previous Close
$4.10
Days Range
- - -
52 week range
$1.89 - $6.37
Volume
0
Avg. Volume (30 days)
1,918,553
Market Cap
$355.04M
Dividend Yield
-
P/E
-
Shares Outstanding
86,596,000
FINANCIAL STATEMENTS FOR PROGENICS PHARMACEUTICALS, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR PROGENICS PHARMACEUTICALS, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Velan Capital, L.P. | 10% Owner | Sep 09, 2019 | Buy | $4.99 | 72,023 | 359,733 | 8,011,733 | Sep 11, 2019, 01:32 PM |
| LTE Partners, LLC | 10% Owner | Sep 09, 2019 | Buy | $4.94 | 21,480 | 106,096 | 1,950,000 | Sep 09, 2019, 06:14 PM |
| LTE Partners, LLC | 10% Owner | Sep 05, 2019 | Buy | $4.62 | 43,520 | 201,097 | 1,928,520 | Sep 09, 2019, 06:14 PM |
| Velan Capital, L.P. | 10% Owner | Sep 04, 2019 | Buy | $4.51 | 243,614 | 1,098,529 | 7,939,710 | Sep 05, 2019, 04:37 PM |
| Velan Capital, L.P. | 10% Owner | Sep 03, 2019 | Buy | $4.39 | 277,424 | 1,218,918 | 7,696,096 | Sep 05, 2019, 04:37 PM |
| Velan Capital, L.P. | 10% Owner | Aug 26, 2019 | Buy | $4.30 | 73,230 | 314,911 | 7,418,672 | Aug 27, 2019, 03:45 PM |
| Velan Capital, L.P. | 10% Owner | Aug 23, 2019 | Buy | $4.31 | 130,826 | 563,690 | 7,345,442 | Aug 27, 2019, 03:45 PM |
| Campbell Bradley L | Director | Jul 03, 2019 | Option Exercise | $4.89 | 12,000 | 58,680 | 12,000 | Jul 08, 2019, 12:32 PM |
| SCHEINBERG DAVID A | Director | Jul 01, 2019 | Option Exercise | $5.33 | 10,000 | 53,300 | 56,185 | Jul 03, 2019, 08:56 AM |
| Crowley Peter J | Director | Jun 26, 2019 | Option Exercise | $5.35 | 50,000 | 267,300 | 50,000 | Jun 27, 2019, 04:33 PM |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | Feb 15, 2017 | Sale | $9.55 | 150,000 | 1,432,500 | 6,997,269 | Feb 15, 2017, 05:13 PM |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | Feb 14, 2017 | Sale | $9.69 | 352,600 | 3,417,220 | 7,447,269 | Feb 15, 2017, 05:13 PM |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | Feb 13, 2017 | Sale | $9.70 | 100,000 | 970,000 | 7,499,869 | Feb 15, 2017, 05:13 PM |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | Feb 07, 2017 | Sale | $9.71 | 150,000 | 1,456,500 | 7,851,169 | Feb 09, 2017, 04:40 PM |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | Feb 09, 2017 | Sale | $9.70 | 201,300 | 1,953,590 | 7,701,169 | Feb 09, 2017, 04:40 PM |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | Jan 11, 2017 | Option Exercise | $8.95 | 1,000,000 | 8,950,000 | 7,951,169 | Jan 13, 2017, 04:28 PM |
| MADDON PAUL J | Director | Dec 01, 2010 | Buy | $4.90 | 5,000 | 24,500 | 909,891 | Apr 22, 2016, 05:09 PM |
| ISRAEL ROBERT J | Executive Vice President, Medi | Jun 11, 2015 | Option Exercise | $5.33 | 2,000 | 10,660 | 37,050 | Jun 15, 2015, 09:32 AM |
| ISRAEL ROBERT J | Executive Vice President, Medi | Jun 11, 2015 | Sale | $6.83 | 2,000 | 13,660 | 35,050 | Jun 15, 2015, 09:32 AM |
| ISRAEL ROBERT J | Executive Vice President, Medi | Mar 13, 2015 | Option Exercise | $5.35 | 3,000 | 16,050 | 38,050 | Mar 16, 2015, 12:26 PM |
| ISRAEL ROBERT J | Executive Vice President, Medi | Mar 13, 2015 | Sale | $7.00 | 3,000 | 21,000 | 35,050 | Mar 16, 2015, 12:26 PM |
| ISRAEL ROBERT J | Executive Vice President, Medi | Mar 11, 2015 | Option Exercise | $5.33 | 2,000 | 10,660 | 37,050 | Mar 13, 2015, 09:26 AM |
| ISRAEL ROBERT J | Executive Vice President, Medi | Mar 11, 2015 | Sale | $6.83 | 2,000 | 13,660 | 35,050 | Mar 13, 2015, 09:26 AM |
| ISRAEL ROBERT J | Executive Vice President, Medi | Mar 03, 2015 | Option Exercise | $4.70 | 5,000 | 23,500 | 40,050 | Mar 04, 2015, 02:55 PM |
| ISRAEL ROBERT J | Executive Vice President, Medi | Mar 03, 2015 | Sale | $6.49 | 5,000 | 32,450 | 35,050 | Mar 04, 2015, 02:55 PM |
| ISRAEL ROBERT J | Executive Vice President, Medi | Jan 12, 2015 | Option Exercise | $5.33 | 2,000 | 10,660 | 37,050 | Jan 13, 2015, 01:48 PM |
| ISRAEL ROBERT J | Executive Vice President, Medi | Jan 12, 2015 | Sale | $7.06 | 2,000 | 14,112 | 35,050 | Jan 13, 2015, 01:48 PM |
| ISRAEL ROBERT J | Executive Vice President, Medi | Dec 11, 2014 | Option Exercise | $5.35 | 3,000 | 16,050 | 38,050 | Dec 12, 2014, 11:27 AM |
| ISRAEL ROBERT J | Executive Vice President, Medi | Dec 11, 2014 | Sale | $7.07 | 3,000 | 21,201 | 35,050 | Dec 12, 2014, 11:27 AM |
| ISRAEL ROBERT J | Executive Vice President, Medi | Nov 21, 2014 | Option Exercise | $5.35 | 9,000 | 48,150 | 44,050 | Nov 21, 2014, 05:06 PM |
| ISRAEL ROBERT J | Executive Vice President, Medi | Nov 21, 2014 | Sale | $7.00 | 9,000 | 63,000 | 35,050 | Nov 21, 2014, 05:06 PM |
| ISRAEL ROBERT J | Executive Vice President, Medi | Nov 13, 2014 | Option Exercise | $5.33 | 10,000 | 53,300 | 45,050 | Nov 14, 2014, 04:38 PM |
| ISRAEL ROBERT J | Executive Vice President, Medi | Nov 13, 2014 | Sale | $6.83 | 10,000 | 68,300 | 35,050 | Nov 14, 2014, 04:38 PM |
| ISRAEL ROBERT J | Executive Vice President, Medi | Nov 11, 2014 | Option Exercise | $5.03 | 5,000 | 25,150 | 40,050 | Nov 12, 2014, 09:31 AM |
| ISRAEL ROBERT J | Executive Vice President, Medi | Nov 11, 2014 | Sale | $6.53 | 5,000 | 32,650 | 35,050 | Nov 12, 2014, 09:31 AM |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | Jul 21, 2014 | Buy | $4.73 | 388,659 | 1,838,357 | 8,951,169 | Jul 23, 2014, 10:42 AM |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | Jul 18, 2014 | Buy | $4.73 | 388,200 | 1,836,186 | 8,562,510 | Jul 23, 2014, 10:42 AM |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | Jul 17, 2014 | Buy | $4.48 | 436,884 | 1,957,240 | 8,174,310 | Jul 23, 2014, 10:42 AM |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | Jul 16, 2014 | Buy | $4.48 | 411,693 | 1,844,385 | 7,737,426 | Jul 23, 2014, 10:42 AM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Jul 18, 2013 | Option Exercise | $5.33 | 5,000 | 26,650 | 40,050 | Jul 22, 2013, 01:16 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Jul 18, 2013 | Sale | $6.33 | 5,000 | 31,650 | 35,050 | Jul 22, 2013, 01:16 PM |
| Baker Mark Robert | CEO | Mar 27, 2013 | Buy | $5.32 | 650 | 3,458 | 161,141 | Mar 28, 2013, 09:24 AM |
| SCHEINBERG DAVID A | Director | Mar 22, 2013 | Option Exercise | $3.64 | 2,500 | 9,098 | 47,435 | Mar 22, 2013, 05:14 PM |
| Baker Mark Robert | CEO | Feb 27, 2013 | Buy | $2.72 | 1,262 | 3,434 | 160,491 | Feb 28, 2013, 05:24 PM |
| Baker Mark Robert | CEO | Jan 22, 2013 | Buy | $2.82 | 1,215 | 3,429 | 159,229 | Jan 23, 2013, 09:59 AM |
| Baker Mark Robert | CEO | Dec 26, 2012 | Buy | $3.01 | 1,142 | 3,437 | 158,014 | Dec 26, 2012, 01:05 PM |
| Baker Mark Robert | CEO | Nov 28, 2012 | Buy | $2.13 | 1,607 | 3,419 | 156,872 | Nov 30, 2012, 12:07 PM |
| Baker Mark Robert | CEO | Nov 19, 2012 | Buy | $1.96 | 11,800 | 23,104 | 155,265 | Nov 20, 2012, 01:41 PM |
| Baker Mark Robert | CEO | Nov 16, 2012 | Buy | $1.82 | 49,793 | 90,723 | 143,465 | Nov 19, 2012, 01:50 PM |
| Baker Mark Robert | CEO | Nov 15, 2012 | Buy | $1.69 | 48,833 | 82,332 | 93,672 | Nov 16, 2012, 01:54 PM |
| Baker Mark Robert | CEO | Oct 24, 2012 | Buy | $2.95 | 1,162 | 3,434 | 44,839 | Oct 25, 2012, 11:34 AM |
| Baker Mark Robert | CEO | Sep 26, 2012 | Buy | $3.32 | 1,036 | 3,440 | 43,677 | Sep 27, 2012, 03:14 PM |
| Baker Mark Robert | CEO | Aug 22, 2012 | Buy | $4.23 | 815 | 3,451 | 42,641 | Aug 23, 2012, 09:44 AM |
| Baker Mark Robert | CEO | Jul 25, 2012 | Buy | $10.04 | 346 | 3,473 | 41,826 | Jul 26, 2012, 11:42 AM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Jul 02, 2012 | Option Exercise | $5.33 | 1,000 | 5,330 | 36,050 | Jul 03, 2012, 01:19 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Jul 02, 2012 | Sale | $9.79 | 1,000 | 9,790 | 35,050 | Jul 03, 2012, 01:19 PM |
| Baker Mark Robert | CEO | Jun 27, 2012 | Buy | $9.27 | 375 | 3,477 | 41,480 | Jun 29, 2012, 09:15 AM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Jun 20, 2012 | Option Exercise | $8.58 | 3,333 | 28,604 | 35,050 | Jun 22, 2012, 03:01 PM |
| Olson William C | Senior VP, Research and Develo | Jun 20, 2012 | Option Exercise | $8.69 | 1,230 | 10,685 | 45,544 | Jun 22, 2012, 03:00 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Jun 01, 2012 | Option Exercise | $5.33 | 1,000 | 5,330 | 39,383 | Jun 04, 2012, 04:49 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Jun 01, 2012 | Sale | $8.51 | 1,000 | 8,508 | 38,383 | Jun 04, 2012, 04:49 PM |
| Baker Mark Robert | CEO | May 23, 2012 | Buy | $7.81 | 445 | 3,475 | 41,105 | May 24, 2012, 12:38 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | May 01, 2012 | Option Exercise | $5.33 | 1,000 | 5,330 | 39,383 | May 03, 2012, 11:25 AM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | May 01, 2012 | Sale | $10.93 | 1,000 | 10,927 | 38,383 | May 03, 2012, 11:25 AM |
| Baker Mark Robert | CEO | Apr 25, 2012 | Buy | $10.07 | 348 | 3,506 | 40,660 | Apr 27, 2012, 09:23 AM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Apr 02, 2012 | Option Exercise | $5.33 | 1,000 | 5,330 | 39,383 | Apr 03, 2012, 11:55 AM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Apr 02, 2012 | Sale | $9.85 | 1,000 | 9,852 | 38,383 | Apr 03, 2012, 11:55 AM |
| Baker Mark Robert | CEO | Mar 28, 2012 | Buy | $10.13 | 343 | 3,475 | 40,312 | Mar 29, 2012, 03:12 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Mar 01, 2012 | Option Exercise | $5.33 | 1,000 | 5,330 | 39,383 | Mar 02, 2012, 04:29 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Mar 01, 2012 | Sale | $9.82 | 1,000 | 9,817 | 38,383 | Mar 02, 2012, 04:29 PM |
| SCHEINBERG DAVID A | Director | Feb 23, 2012 | Option Exercise | $6.90 | 1,250 | 8,625 | 47,435 | Feb 27, 2012, 05:53 PM |
| SCHEINBERG DAVID A | Director | Feb 23, 2012 | Sale | $10.00 | 1,250 | 12,500 | 46,185 | Feb 27, 2012, 05:53 PM |
| Baker Mark Robert | CEO | Feb 22, 2012 | Buy | $9.41 | 369 | 3,474 | 39,969 | Feb 23, 2012, 09:28 AM |
| BRINER KURT W | Director | Feb 03, 2012 | Sale | $10.22 | 33,000 | 337,227 | 0 | Feb 03, 2012, 05:48 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Feb 01, 2012 | Option Exercise | $5.33 | 1,000 | 5,330 | 39,383 | Feb 02, 2012, 10:48 AM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Feb 01, 2012 | Sale | $9.48 | 1,000 | 9,478 | 38,383 | Feb 02, 2012, 10:48 AM |
| Baker Mark Robert | CEO | Jan 25, 2012 | Buy | $9.53 | 364 | 3,470 | 39,600 | Jan 26, 2012, 10:05 AM |
| Baker Mark Robert | CEO | Jan 11, 2012 | Buy | $8.87 | 391 | 3,466 | 39,236 | Jan 12, 2012, 01:16 PM |
| Baker Mark Robert | CEO | Oct 26, 2011 | Buy | $6.52 | 532 | 3,467 | 38,211 | Jan 12, 2012, 01:16 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Jan 03, 2012 | Option Exercise | $5.33 | 1,000 | 5,330 | 39,383 | Jan 04, 2012, 01:24 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Jan 03, 2012 | Sale | $8.78 | 1,000 | 8,780 | 38,383 | Jan 04, 2012, 01:24 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Dec 01, 2011 | Option Exercise | $5.33 | 1,000 | 5,330 | 39,383 | Dec 02, 2011, 02:57 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Dec 01, 2011 | Sale | $6.66 | 1,000 | 6,660 | 38,383 | Dec 02, 2011, 02:57 PM |
| Baker Mark Robert | CEO | Nov 23, 2011 | Sale | $5.45 | 634 | 3,455 | 38,313 | Nov 28, 2011, 02:18 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Nov 01, 2011 | Option Exercise | $5.33 | 1,000 | 5,330 | 39,383 | Nov 01, 2011, 05:23 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Nov 01, 2011 | Sale | $6.33 | 1,000 | 6,330 | 38,383 | Nov 01, 2011, 05:23 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Oct 05, 2011 | Option Exercise | $5.33 | 1,000 | 5,330 | 39,383 | Oct 05, 2011, 05:16 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Oct 05, 2011 | Sale | $6.33 | 1,000 | 6,330 | 38,383 | Oct 05, 2011, 05:16 PM |
| Olson William C | Senior VP, Research and Develo | Oct 03, 2011 | Option Exercise | $5.44 | 2,356 | 12,817 | 46,774 | Oct 04, 2011, 05:24 PM |
| Olson William C | Senior VP, Research and Develo | Oct 03, 2011 | Option Exercise | $4.62 | 2,605 | 12,046 | 49,130 | Oct 04, 2011, 05:24 PM |
| MCKINNEY ROBERT A | Senior VP, CFO | Oct 03, 2011 | Option Exercise | $5.44 | 2,475 | 13,464 | 44,415 | Oct 04, 2011, 05:23 PM |
| MCKINNEY ROBERT A | Senior VP, CFO | Oct 03, 2011 | Option Exercise | $4.62 | 2,737 | 12,656 | 46,890 | Oct 04, 2011, 05:23 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Oct 03, 2011 | Option Exercise | $5.44 | 3,290 | 17,898 | 38,383 | Oct 04, 2011, 05:22 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Oct 03, 2011 | Option Exercise | $4.62 | 3,638 | 16,822 | 41,673 | Oct 04, 2011, 05:22 PM |
| Baker Mark Robert | CEO | Oct 03, 2011 | Option Exercise | $5.44 | 4,666 | 25,383 | 37,679 | Oct 04, 2011, 05:20 PM |
| Baker Mark Robert | CEO | Oct 03, 2011 | Option Exercise | $4.62 | 5,124 | 23,693 | 42,345 | Oct 04, 2011, 05:20 PM |
| Baker Mark Robert | CEO | Sep 28, 2011 | Buy | $6.39 | 542 | 3,463 | 37,029 | Sep 28, 2011, 04:55 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Sep 27, 2011 | Option Exercise | $5.33 | 746 | 3,976 | 38,589 | Sep 28, 2011, 09:49 AM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Sep 27, 2011 | Sale | $6.33 | 746 | 4,722 | 37,843 | Sep 28, 2011, 09:49 AM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Sep 20, 2011 | Option Exercise | $5.33 | 100 | 533 | 37,943 | Sep 21, 2011, 12:22 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Sep 20, 2011 | Sale | $6.33 | 100 | 633 | 37,843 | Sep 21, 2011, 12:22 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Sep 01, 2011 | Option Exercise | $5.33 | 154 | 821 | 37,997 | Sep 06, 2011, 02:11 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Sep 01, 2011 | Sale | $6.33 | 154 | 975 | 37,843 | Sep 06, 2011, 02:11 PM |
| Baker Mark Robert | CEO | Aug 24, 2011 | Buy | $6.08 | 571 | 3,472 | 36,487 | Aug 25, 2011, 09:31 AM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Aug 11, 2011 | Option Exercise | $5.33 | 1,000 | 5,330 | 38,843 | Aug 12, 2011, 11:31 AM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Aug 11, 2011 | Sale | $6.33 | 1,000 | 6,330 | 37,843 | Aug 12, 2011, 11:31 AM |
| Baker Mark Robert | CEO | Jul 27, 2011 | Buy | $6.12 | 567 | 3,472 | 35,916 | Jul 28, 2011, 05:06 PM |
| MCKINNEY ROBERT A | Senior VP, CFO | Jul 01, 2011 | Option Exercise | $7.40 | 6,062 | 44,859 | 43,961 | Jul 06, 2011, 06:58 PM |
| MCKINNEY ROBERT A | Senior VP, CFO | Jul 01, 2011 | Option Exercise | $5.46 | 7,279 | 39,743 | 50,023 | Jul 06, 2011, 06:58 PM |
| Olson William C | Senior VP, Research and Develo | Jul 01, 2011 | Option Exercise | $7.40 | 5,276 | 39,042 | 46,333 | Jul 06, 2011, 06:57 PM |
| Olson William C | Senior VP, Research and Develo | Jul 01, 2011 | Option Exercise | $5.46 | 6,335 | 34,589 | 51,609 | Jul 06, 2011, 06:57 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Jul 01, 2011 | Option Exercise | $7.40 | 6,930 | 51,282 | 37,843 | Jul 06, 2011, 06:55 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Jul 01, 2011 | Option Exercise | $5.45 | 9,322 | 50,768 | 44,773 | Jul 06, 2011, 06:55 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Jul 01, 2011 | Sale | $7.20 | 1,000 | 7,205 | 36,151 | Jul 06, 2011, 06:55 PM |
| Baker Mark Robert | CEO | Jul 01, 2011 | Option Exercise | $7.40 | 16,905 | 125,097 | 35,349 | Jul 06, 2011, 06:49 PM |
| Baker Mark Robert | CEO | Jul 01, 2011 | Option Exercise | $5.46 | 20,032 | 109,375 | 52,254 | Jul 06, 2011, 06:49 PM |
| Baker Mark Robert | CEO | Jun 22, 2011 | Buy | $7.08 | 490 | 3,469 | 31,922 | Jun 24, 2011, 10:07 AM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Jun 21, 2011 | Sale | $7.01 | 7,889 | 55,341 | 36,151 | Jun 22, 2011, 04:54 PM |
| Olson William C | Senior VP, Research and Develo | Jun 21, 2011 | Sale | $7.09 | 2,872 | 20,359 | 45,080 | Jun 22, 2011, 04:53 PM |
| MCKINNEY ROBERT A | Senior VP, CFO | Jun 17, 2011 | Sale | $7.50 | 3,000 | 22,500 | 42,444 | Jun 20, 2011, 11:27 AM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Jun 01, 2011 | Option Exercise | $5.33 | 1,000 | 5,330 | 45,040 | Jun 02, 2011, 03:08 PM |
| ISRAEL ROBERT J | Senior VP Medical Affairs | Jun 01, 2011 | Sale | $8.15 | 1,000 | 8,153 | 44,040 | Jun 02, 2011, 03:08 PM |
| Baker Mark Robert | CEO | May 25, 2011 | Buy | $7.13 | 486 | 3,465 | 31,432 | May 26, 2011, 03:15 PM |
| BRINER KURT W | Director | May 16, 2011 | Sale | $8.19 | 5,000 | 40,925 | 33,000 | May 17, 2011, 03:26 PM |
| BRINER KURT W | Director | May 13, 2011 | Sale | $8.27 | 15,000 | 123,975 | 38,000 | May 17, 2011, 03:26 PM |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | May 02, 2011 | Option Exercise | $5.33 | 1,000 | 5,330 | 45,040 | May 04, 2011, 03:30 PM |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | May 02, 2011 | Sale | $7.39 | 1,000 | 7,390 | 44,040 | May 04, 2011, 03:30 PM |
| Baker Mark Robert | CEO | Apr 27, 2011 | Buy | $7.24 | 479 | 3,468 | 30,946 | Apr 27, 2011, 04:05 PM |
| MCKINNEY ROBERT A | Chief Financial Officer | Apr 01, 2011 | Option Exercise | $6.29 | 2,181 | 13,718 | 45,444 | Apr 05, 2011, 09:54 AM |
| MCKINNEY ROBERT A | Chief Financial Officer | Apr 01, 2011 | Option Exercise | $5.05 | 2,495 | 12,600 | 47,625 | Apr 05, 2011, 09:54 AM |
| Baker Mark Robert | President | Apr 01, 2011 | Option Exercise | $6.29 | 3,550 | 22,329 | 30,467 | Apr 05, 2011, 09:51 AM |
| Baker Mark Robert | President | Apr 01, 2011 | Option Exercise | $5.05 | 4,022 | 20,311 | 34,017 | Apr 05, 2011, 09:51 AM |
| Olson William C | SR. VP, Research & Development | Apr 01, 2011 | Option Exercise | $6.29 | 2,075 | 13,052 | 47,846 | Apr 05, 2011, 09:50 AM |
| Olson William C | SR. VP, Research & Development | Apr 01, 2011 | Option Exercise | $5.05 | 2,373 | 11,984 | 49,921 | Apr 05, 2011, 09:50 AM |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | Apr 01, 2011 | Option Exercise | $6.29 | 2,913 | 18,323 | 44,040 | Apr 05, 2011, 09:48 AM |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | Apr 01, 2011 | Option Exercise | $5.11 | 4,332 | 22,157 | 46,953 | Apr 05, 2011, 09:48 AM |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | Apr 01, 2011 | Sale | $6.33 | 1,000 | 6,330 | 43,377 | Apr 05, 2011, 09:48 AM |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | Mar 29, 2011 | Option Exercise | $5.33 | 800 | 4,264 | 44,177 | Mar 30, 2011, 04:28 PM |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | Mar 29, 2011 | Sale | $6.33 | 800 | 5,064 | 43,377 | Mar 30, 2011, 04:28 PM |
| GOFF STEPHEN P | Director | Mar 09, 2011 | Option Exercise | $1.33 | 32,500 | 43,225 | 66,000 | Mar 11, 2011, 05:25 PM |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | Mar 08, 2011 | Option Exercise | $5.33 | 200 | 1,066 | 43,577 | Mar 09, 2011, 02:11 PM |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | Mar 08, 2011 | Sale | $6.33 | 200 | 1,266 | 43,377 | Mar 09, 2011, 02:11 PM |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | Feb 07, 2011 | Option Exercise | $5.33 | 7,597 | 40,492 | 50,974 | Feb 08, 2011, 04:31 PM |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | Feb 07, 2011 | Sale | $6.33 | 7,597 | 48,089 | 43,377 | Feb 08, 2011, 04:31 PM |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | Jan 19, 2011 | Option Exercise | $5.33 | 403 | 2,148 | 43,780 | Jan 20, 2011, 04:11 PM |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | Jan 19, 2011 | Sale | $6.33 | 403 | 2,551 | 43,377 | Jan 20, 2011, 04:11 PM |
| MCKINNEY ROBERT A | Chief Financial Officer | Jan 03, 2011 | Option Exercise | $5.68 | 2,473 | 14,047 | 44,886 | Jan 05, 2011, 04:33 PM |
| MCKINNEY ROBERT A | Chief Financial Officer | Jan 03, 2011 | Option Exercise | $4.83 | 2,715 | 13,108 | 47,359 | Jan 05, 2011, 04:33 PM |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | Jan 03, 2011 | Option Exercise | $5.68 | 3,301 | 18,750 | 43,377 | Jan 05, 2011, 04:32 PM |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | Jan 03, 2011 | Option Exercise | $4.83 | 3,625 | 17,502 | 46,678 | Jan 05, 2011, 04:32 PM |
| Olson William C | SR. VP, Research & Development | Jan 03, 2011 | Option Exercise | $5.68 | 2,351 | 13,354 | 47,304 | Jan 05, 2011, 04:31 PM |
| Olson William C | SR. VP, Research & Development | Jan 03, 2011 | Option Exercise | $4.83 | 2,582 | 12,466 | 49,655 | Jan 05, 2011, 04:31 PM |
| Baker Mark Robert | President | Jan 03, 2011 | Option Exercise | $5.68 | 4,014 | 22,800 | 29,751 | Jan 05, 2011, 04:29 PM |
| Baker Mark Robert | President | Jan 03, 2011 | Option Exercise | $4.83 | 4,377 | 21,132 | 33,765 | Jan 05, 2011, 04:29 PM |
| MADDON PAUL J | Chief Executive Officer/CSO | Dec 01, 2010 | Buy | $4.90 | 5,000 | 24,500 | 854,057 | Dec 01, 2010, 04:12 PM |
| MADDON PAUL J | Chief Executive Officer/CSO | Nov 01, 2010 | Buy | $4.76 | 5,000 | 23,800 | 849,057 | Nov 02, 2010, 11:54 AM |
| Olson William C | SR. VP, Research & Development | Oct 01, 2010 | Option Exercise | $5.08 | 6,254 | 31,770 | 46,871 | Oct 04, 2010, 05:42 PM |
| Olson William C | SR. VP, Research & Development | Oct 01, 2010 | Option Exercise | $4.32 | 6,915 | 29,859 | 53,125 | Oct 04, 2010, 05:42 PM |
| MCKINNEY ROBERT A | Chief Financial Officer | Oct 01, 2010 | Option Exercise | $5.08 | 7,442 | 37,805 | 44,442 | Oct 04, 2010, 05:41 PM |
| MCKINNEY ROBERT A | Chief Financial Officer | Oct 01, 2010 | Option Exercise | $4.32 | 8,229 | 35,533 | 51,884 | Oct 04, 2010, 05:41 PM |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | Oct 01, 2010 | Option Exercise | $5.08 | 7,945 | 40,361 | 42,851 | Oct 04, 2010, 05:40 PM |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | Oct 01, 2010 | Option Exercise | $4.32 | 8,786 | 37,938 | 50,796 | Oct 04, 2010, 05:40 PM |
| Baker Mark Robert | President | Oct 01, 2010 | Option Exercise | $5.08 | 15,972 | 81,138 | 29,186 | Oct 04, 2010, 05:39 PM |
| Baker Mark Robert | President | Oct 01, 2010 | Option Exercise | $4.32 | 17,545 | 75,759 | 45,158 | Oct 04, 2010, 05:39 PM |
| MADDON PAUL J | Chief Executive Officer/CSO | Oct 04, 2010 | Buy | $4.99 | 5,000 | 24,950 | 844,057 | Oct 04, 2010, 05:37 PM |
| MADDON PAUL J | Chief Executive Officer/CSO | Sep 01, 2010 | Buy | $4.10 | 5,000 | 20,500 | 839,057 | Sep 02, 2010, 10:39 AM |
| MADDON PAUL J | Chief Executive Officer/CSO | Aug 02, 2010 | Buy | $4.75 | 5,000 | 23,750 | 834,057 | Aug 02, 2010, 05:13 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Velan Capital, L.P. | 10% Owner | 09/09/2019 | 359,733 |
| LTE Partners, LLC | 10% Owner | 09/09/2019 | 106,096 |
| LTE Partners, LLC | 10% Owner | 09/05/2019 | 201,097 |
| Velan Capital, L.P. | 10% Owner | 09/04/2019 | 1,098,529 |
| Velan Capital, L.P. | 10% Owner | 09/03/2019 | 1,218,918 |
| Velan Capital, L.P. | 10% Owner | 08/26/2019 | 314,911 |
| Velan Capital, L.P. | 10% Owner | 08/23/2019 | 563,690 |
| Campbell Bradley L | Director | 07/03/2019 | 58,680 |
| SCHEINBERG DAVID A | Director | 07/01/2019 | 53,300 |
| Crowley Peter J | Director | 06/26/2019 | 267,300 |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | 02/15/2017 | 1,432,500 |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | 02/14/2017 | 3,417,220 |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | 02/13/2017 | 970,000 |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | 02/07/2017 | 1,456,500 |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | 02/09/2017 | 1,953,590 |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | 01/11/2017 | 8,950,000 |
| MADDON PAUL J | Director | 12/01/2010 | 24,500 |
| ISRAEL ROBERT J | Executive Vice President, Medi | 06/11/2015 | 10,660 |
| ISRAEL ROBERT J | Executive Vice President, Medi | 06/11/2015 | 13,660 |
| ISRAEL ROBERT J | Executive Vice President, Medi | 03/13/2015 | 16,050 |
| ISRAEL ROBERT J | Executive Vice President, Medi | 03/13/2015 | 21,000 |
| ISRAEL ROBERT J | Executive Vice President, Medi | 03/11/2015 | 10,660 |
| ISRAEL ROBERT J | Executive Vice President, Medi | 03/11/2015 | 13,660 |
| ISRAEL ROBERT J | Executive Vice President, Medi | 03/03/2015 | 23,500 |
| ISRAEL ROBERT J | Executive Vice President, Medi | 03/03/2015 | 32,450 |
| ISRAEL ROBERT J | Executive Vice President, Medi | 01/12/2015 | 10,660 |
| ISRAEL ROBERT J | Executive Vice President, Medi | 01/12/2015 | 14,112 |
| ISRAEL ROBERT J | Executive Vice President, Medi | 12/11/2014 | 16,050 |
| ISRAEL ROBERT J | Executive Vice President, Medi | 12/11/2014 | 21,201 |
| ISRAEL ROBERT J | Executive Vice President, Medi | 11/21/2014 | 48,150 |
| ISRAEL ROBERT J | Executive Vice President, Medi | 11/21/2014 | 63,000 |
| ISRAEL ROBERT J | Executive Vice President, Medi | 11/13/2014 | 53,300 |
| ISRAEL ROBERT J | Executive Vice President, Medi | 11/13/2014 | 68,300 |
| ISRAEL ROBERT J | Executive Vice President, Medi | 11/11/2014 | 25,150 |
| ISRAEL ROBERT J | Executive Vice President, Medi | 11/11/2014 | 32,650 |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | 07/21/2014 | 1,838,357 |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | 07/18/2014 | 1,836,186 |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | 07/17/2014 | 1,957,240 |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | 07/16/2014 | 1,844,385 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 07/18/2013 | 26,650 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 07/18/2013 | 31,650 |
| Baker Mark Robert | CEO | 03/27/2013 | 3,458 |
| SCHEINBERG DAVID A | Director | 03/22/2013 | 9,098 |
| Baker Mark Robert | CEO | 02/27/2013 | 3,434 |
| Baker Mark Robert | CEO | 01/22/2013 | 3,429 |
| Baker Mark Robert | CEO | 12/26/2012 | 3,437 |
| Baker Mark Robert | CEO | 11/28/2012 | 3,419 |
| Baker Mark Robert | CEO | 11/19/2012 | 23,104 |
| Baker Mark Robert | CEO | 11/16/2012 | 90,723 |
| Baker Mark Robert | CEO | 11/15/2012 | 82,332 |
| Baker Mark Robert | CEO | 10/24/2012 | 3,434 |
| Baker Mark Robert | CEO | 09/26/2012 | 3,440 |
| Baker Mark Robert | CEO | 08/22/2012 | 3,451 |
| Baker Mark Robert | CEO | 07/25/2012 | 3,473 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 07/02/2012 | 5,330 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 07/02/2012 | 9,790 |
| Baker Mark Robert | CEO | 06/27/2012 | 3,477 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 06/20/2012 | 28,604 |
| Olson William C | Senior VP, Research and Develo | 06/20/2012 | 10,685 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 06/01/2012 | 5,330 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 06/01/2012 | 8,508 |
| Baker Mark Robert | CEO | 05/23/2012 | 3,475 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 05/01/2012 | 5,330 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 05/01/2012 | 10,927 |
| Baker Mark Robert | CEO | 04/25/2012 | 3,506 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 04/02/2012 | 5,330 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 04/02/2012 | 9,852 |
| Baker Mark Robert | CEO | 03/28/2012 | 3,475 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 03/01/2012 | 5,330 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 03/01/2012 | 9,817 |
| SCHEINBERG DAVID A | Director | 02/23/2012 | 8,625 |
| SCHEINBERG DAVID A | Director | 02/23/2012 | 12,500 |
| Baker Mark Robert | CEO | 02/22/2012 | 3,474 |
| BRINER KURT W | Director | 02/03/2012 | 337,227 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 02/01/2012 | 5,330 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 02/01/2012 | 9,478 |
| Baker Mark Robert | CEO | 01/25/2012 | 3,470 |
| Baker Mark Robert | CEO | 01/11/2012 | 3,466 |
| Baker Mark Robert | CEO | 10/26/2011 | 3,467 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 01/03/2012 | 5,330 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 01/03/2012 | 8,780 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 12/01/2011 | 5,330 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 12/01/2011 | 6,660 |
| Baker Mark Robert | CEO | 11/23/2011 | 3,455 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 11/01/2011 | 5,330 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 11/01/2011 | 6,330 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 10/05/2011 | 5,330 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 10/05/2011 | 6,330 |
| Olson William C | Senior VP, Research and Develo | 10/03/2011 | 12,817 |
| Olson William C | Senior VP, Research and Develo | 10/03/2011 | 12,046 |
| MCKINNEY ROBERT A | Senior VP, CFO | 10/03/2011 | 13,464 |
| MCKINNEY ROBERT A | Senior VP, CFO | 10/03/2011 | 12,656 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 10/03/2011 | 17,898 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 10/03/2011 | 16,822 |
| Baker Mark Robert | CEO | 10/03/2011 | 25,383 |
| Baker Mark Robert | CEO | 10/03/2011 | 23,693 |
| Baker Mark Robert | CEO | 09/28/2011 | 3,463 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 09/27/2011 | 3,976 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 09/27/2011 | 4,722 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 09/20/2011 | 533 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 09/20/2011 | 633 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 09/01/2011 | 821 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 09/01/2011 | 975 |
| Baker Mark Robert | CEO | 08/24/2011 | 3,472 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 08/11/2011 | 5,330 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 08/11/2011 | 6,330 |
| Baker Mark Robert | CEO | 07/27/2011 | 3,472 |
| MCKINNEY ROBERT A | Senior VP, CFO | 07/01/2011 | 44,859 |
| MCKINNEY ROBERT A | Senior VP, CFO | 07/01/2011 | 39,743 |
| Olson William C | Senior VP, Research and Develo | 07/01/2011 | 39,042 |
| Olson William C | Senior VP, Research and Develo | 07/01/2011 | 34,589 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 07/01/2011 | 51,282 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 07/01/2011 | 50,768 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 07/01/2011 | 7,205 |
| Baker Mark Robert | CEO | 07/01/2011 | 125,097 |
| Baker Mark Robert | CEO | 07/01/2011 | 109,375 |
| Baker Mark Robert | CEO | 06/22/2011 | 3,469 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 06/21/2011 | 55,341 |
| Olson William C | Senior VP, Research and Develo | 06/21/2011 | 20,359 |
| MCKINNEY ROBERT A | Senior VP, CFO | 06/17/2011 | 22,500 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 06/01/2011 | 5,330 |
| ISRAEL ROBERT J | Senior VP Medical Affairs | 06/01/2011 | 8,153 |
| Baker Mark Robert | CEO | 05/25/2011 | 3,465 |
| BRINER KURT W | Director | 05/16/2011 | 40,925 |
| BRINER KURT W | Director | 05/13/2011 | 123,975 |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | 05/02/2011 | 5,330 |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | 05/02/2011 | 7,390 |
| Baker Mark Robert | CEO | 04/27/2011 | 3,468 |
| MCKINNEY ROBERT A | Chief Financial Officer | 04/01/2011 | 13,718 |
| MCKINNEY ROBERT A | Chief Financial Officer | 04/01/2011 | 12,600 |
| Baker Mark Robert | President | 04/01/2011 | 22,329 |
| Baker Mark Robert | President | 04/01/2011 | 20,311 |
| Olson William C | SR. VP, Research & Development | 04/01/2011 | 13,052 |
| Olson William C | SR. VP, Research & Development | 04/01/2011 | 11,984 |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | 04/01/2011 | 18,323 |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | 04/01/2011 | 22,157 |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | 04/01/2011 | 6,330 |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | 03/29/2011 | 4,264 |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | 03/29/2011 | 5,064 |
| GOFF STEPHEN P | Director | 03/09/2011 | 43,225 |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | 03/08/2011 | 1,066 |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | 03/08/2011 | 1,266 |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | 02/07/2011 | 40,492 |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | 02/07/2011 | 48,089 |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | 01/19/2011 | 2,148 |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | 01/19/2011 | 2,551 |
| MCKINNEY ROBERT A | Chief Financial Officer | 01/03/2011 | 14,047 |
| MCKINNEY ROBERT A | Chief Financial Officer | 01/03/2011 | 13,108 |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | 01/03/2011 | 18,750 |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | 01/03/2011 | 17,502 |
| Olson William C | SR. VP, Research & Development | 01/03/2011 | 13,354 |
| Olson William C | SR. VP, Research & Development | 01/03/2011 | 12,466 |
| Baker Mark Robert | President | 01/03/2011 | 22,800 |
| Baker Mark Robert | President | 01/03/2011 | 21,132 |
| MADDON PAUL J | Chief Executive Officer/CSO | 12/01/2010 | 24,500 |
| MADDON PAUL J | Chief Executive Officer/CSO | 11/01/2010 | 23,800 |
| Olson William C | SR. VP, Research & Development | 10/01/2010 | 31,770 |
| Olson William C | SR. VP, Research & Development | 10/01/2010 | 29,859 |
| MCKINNEY ROBERT A | Chief Financial Officer | 10/01/2010 | 37,805 |
| MCKINNEY ROBERT A | Chief Financial Officer | 10/01/2010 | 35,533 |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | 10/01/2010 | 40,361 |
| ISRAEL ROBERT J | Sr. VP, Medical Affairs | 10/01/2010 | 37,938 |
| Baker Mark Robert | President | 10/01/2010 | 81,138 |
| Baker Mark Robert | President | 10/01/2010 | 75,759 |
| MADDON PAUL J | Chief Executive Officer/CSO | 10/04/2010 | 24,950 |
| MADDON PAUL J | Chief Executive Officer/CSO | 09/01/2010 | 20,500 |
| MADDON PAUL J | Chief Executive Officer/CSO | 08/02/2010 | 23,750 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR PROGENICS PHARMACEUTICALS, INC.
LOADING...